Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Donor-Site Outcomes of the Superficial Circumflex Iliac Artery Perforator Flap Versus Radial Forearm Flap in Unilateral Tongue Reconstruction: A Propensity Score Matching Analysis.

Created on 16 Sep 2026

Authors

Wang Wei, Li Xuantao, Zhong Yiwei, Lyu Xiaoming, Zhang Jie

Published in

Head & neck. Sep 16, 2026. Epub Sep 16, 2026.

Abstract

We compared the superficial circumflex iliac artery perforator (SCIP) flap with the radial forearm flap (RFF) to identify limitations restricting its widespread use.
We retrospectively evaluated unilateral tongue reconstruction using propensity score matching for age, sex, T stage, body mass index, and Charlson comorbidity index from a nonfunctional perspective.
Matching 118 patients yielded 27 pairs. Flap survival was comparable. SCIP improved donor-site aesthetics (92.6% vs. 40.7%), preserved strength (100.0% vs. 66.7%), and shortened hospitalization (10.9 vs. 11.9 days). Overall recipient-site and flap-related complications were significantly higher (33.3% vs. 3.7%), driven by Grades I-II events (25.9% vs. 0%). No individual complication category differed significantly. SCIP had a shorter pedicle, more tracheotomies, and greater superior thyroid artery use. Before matching, salvage failed in 5/5 SCIP versus 2/5 RFF cases, an exploratory finding.
SCIP improves donor-site outcomes, but more low-grade complications and vessel considerations may limit widespread adoption.

PMID:
42746856
Bibliographic data and abstract were imported from PubMed on 16 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 18
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement